Lehman Cuts Biotech Sector to Neutral
Lehman Brothers downgraded the biotech sector to neutral from positive. CancerVax (CNVX ) was one of the biotech stocks that fell on the comments.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.